So, $2.5 million now and another $2.5 million via the options to be converted over the next 12 months (once the dust settles and the options are being converted)?
That, plus the ongoing Lind payments, the remainder of the R&D Refund in January (2023: $7.36 million, gut feel is we spent more this year, hence refund likely to be higher, but less advance of $1.5 million received) should give us a long enough cash runway until (positive) news regarding our ongoing trials drop.
Let the market open and stale holders sell out.
Ann: $5 million Placement to progress CHM CDH17 trial, page-3
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $8.060M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.4¢ | 0.4¢ | $19.57K | 4.893M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 419507 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 18587873 | 22 |
View Market Depth
| Last trade - 15.59pm 27/06/2025 (20 minute delay) ? |
| CHM (ASX) Chart |